We examined changes in tumor volume over time for all models treated with flavopiridol relative to the vehicle-treated arm and demonstrated that flavopiridol treatment resulted in reduction in both tumor size, weight and protein expression of the marker Ki67 associated with cellular proliferation as indicated by immunohistochemistry studies. The gene discussed is MKI67; the disease is neoplasm.